Oxford Biomedica......the next level !!!!

Knackers (Post 14773) I am correct:

1) Price 30/12/2001: approx 34p.
2) Price 30/12/2004: 17p.

The current price is therefore half what it was 3 years ago. The market does not appear to consider OXB to be a good investment.

I genuinly suggest you take a look at Alizyme (AZM) for obvious reasons of anticipated newsflow on out-licensing deals for COLAL-PRED and the potential blockbuster Renzapride during the next 12 weeks, advanced pipeline, and comparatively low risk. Also out-licensing of the potential blockbuster ATL-962 in H2 2004 or H1 2005. Possibly the best UK biotech prospect for 2005 imo.